These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 22499962)

  • 21. An evaluation of empiric vs. nomogram-based dosing of heparin in an intensive care unit.
    Brown G; Dodek P
    Crit Care Med; 1997 Sep; 25(9):1534-8. PubMed ID: 9295828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of 2 weight-based heparin dosing nomograms in neurology and vascular surgical patients.
    Marotti SB; Barras M; Kirkpatrick C
    Ther Drug Monit; 2015 Feb; 37(1):33-9. PubMed ID: 24831654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of an intravenous heparin nomogram in a coronary care unit.
    Paradiso-Hardy FL; Cheung B; Geerts WH
    Can J Cardiol; 1996 Sep; 12(9):802-8. PubMed ID: 8842133
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of weight-based dosing of unfractionated heparin in obese children.
    Taylor BN; Bork SJ; Kim S; Moffett BS; Yee DL
    J Pediatr; 2013 Jul; 163(1):150-3. PubMed ID: 23414664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heparin dosing in obese pediatric patients in the cardiac catheterization laboratory.
    Moffett BS; Teruya J; Petit C
    Ann Pharmacother; 2011 Jul; 45(7-8):876-80. PubMed ID: 21775696
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Appropriate use of heparin. Empiric vs nomogram-based dosing.
    Gunnarsson PS; Sawyer WT; Montague D; Williams ML; Dupuis RE; Caiola SM
    Arch Intern Med; 1995 Mar; 155(5):526-32. PubMed ID: 7864708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of a heparin nomogram for treatment of patients with venous thromboembolism in a community hospital.
    de Groot MR; Büller HR; ten Cate JW; van Marwijk Kooy M
    Thromb Haemost; 1998 Jul; 80(1):70-3. PubMed ID: 9684788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosis.
    Hull RD; Raskob GE; Brant RF; Pineo GF; Valentine KA
    Arch Intern Med; 1997 Dec 8-22; 157(22):2562-8. PubMed ID: 9531224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The successful application of a heparin nomogram in a community hospital.
    Hollingsworth JA; Rowe BH; Brisebois FJ; Thompson PR; Fabris LM
    Arch Intern Med; 1995 Oct; 155(19):2095-100. PubMed ID: 7575069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized trial comparing activated thromboplastin time with heparin assay in patients with acute venous thromboembolism requiring large daily doses of heparin.
    Levine MN; Hirsh J; Gent M; Turpie AG; Cruickshank M; Weitz J; Anderson D; Johnson M
    Arch Intern Med; 1994 Jan; 154(1):49-56. PubMed ID: 8267489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use and limitations of unfractionated heparin.
    Krishnaswamy A; Lincoff AM; Cannon CP
    Crit Pathw Cardiol; 2010 Mar; 9(1):35-40. PubMed ID: 20215909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identifying optimal initial infusion rates for unfractionated heparin in morbidly obese patients.
    Riney JN; Hollands JM; Smith JR; Deal EN
    Ann Pharmacother; 2010; 44(7-8):1141-51. PubMed ID: 20587743
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quality of anticoagulation with unfractionated heparin plus phenprocoumon for the prevention of thromboembolic complications in cardioversion for non-valvular atrial fibrillation. Sub-analysis from the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial.
    Schmidt-Lucke C; Paar WD; Stellbrink C; Nixdorff U; Hofmann T; Meurer J; Grewe R; Daniel WG; Hanrath P; Mügge A; Klein HU; Schmidt-Lucke JA
    Thromb Res; 2007; 119(1):27-34. PubMed ID: 16443257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Limitations of a standardized weight-based nomogram for heparin dosing in patients with morbid obesity.
    Barletta JF; DeYoung JL; McAllen K; Baker R; Pendleton K
    Surg Obes Relat Dis; 2008; 4(6):748-53. PubMed ID: 18586569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of weight, sex, age, clinical diagnosis, and thromboplastin reagent on steady-state intravenous heparin requirements.
    White RH; Zhou H; Woo L; Mungall D
    Arch Intern Med; 1997 Nov; 157(21):2468-72. PubMed ID: 9385298
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group.
    Koopman MM; Prandoni P; Piovella F; Ockelford PA; Brandjes DP; van der Meer J; Gallus AS; Simonneau G; Chesterman CH; Prins MH
    N Engl J Med; 1996 Mar; 334(11):682-7. PubMed ID: 8594426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Computer-assisted dosing of heparin. Management with a pharmacy-based anticoagulation service.
    Kershaw B; White RH; Mungall D; Van Houten J; Brettfeld S
    Arch Intern Med; 1994 May; 154(9):1005-11. PubMed ID: 8179443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of anti-Xa and activated partial thromboplastin time monitoring for heparin dosing in patients with cirrhosis.
    Fuentes A; Gordon-Burroughs S; Hall JB; Putney DR; Monsour HP
    Ther Drug Monit; 2015 Feb; 37(1):40-4. PubMed ID: 24901494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of an Unfractionated Heparin Pharmacy Dosing Protocol for the Treatment of Venous Thromboembolism in Nonobese, Obese, and Severely Obese Patients.
    Hosch LM; Breedlove EY; Scono LE; Knoderer CA
    Ann Pharmacother; 2017 Sep; 51(9):768-773. PubMed ID: 28511582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reevaluation of a weight-based heparin dosing nomogram: is institution-specific modification necessary?
    Schlicht JR; Sunyecz L; Weber RJ; Tabas GH; Smith RE
    Ann Pharmacother; 1997 Dec; 31(12):1454-9. PubMed ID: 9416380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.